Aster DM Quality

Why is Aster DM Healthcare Ltd falling/rising?

As of 06-Aug, Aster DM Quality Care Ltd's stock price is at 844.40, having increased by 3.65 (0.43%). The stock has shown strong long-term performance, with a year-to-date rise of 37.02% and a new all-time high of Rs. 874, despite a recent trend reversal.

As of 06-Aug, Aster DM Quality Care Ltd's stock price is rising, currently at 844.40, reflecting an increase of 3.65 (0.43%). The stock has shown strong performance over various periods, with a year-to-date increase of 37.02% compared to a decline of 7.35% in the Sensex. Over the past year, the stock has risen by 41.26%, significantly outperforming the broader market.<BR><BR>Today, the stock reached a new 52-week and all-time high of Rs. 874, indicating positive momentum. Despite a slight underperformance against its sector by 0.64% today, the stock has been trading above its moving averages across multiple time frames, which suggests a strong upward trend. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 98.32% compared to the 5-day average, indicating growing interest among investors.<BR><BR>However, it is important to note that the stock has experienced a trend reversal after two consecutive days of gains, touching an intraday low of Rs. 811.25. Despite this, the overall long-term performance remains robust, supported by high management efficiency and a return on equity (ROE) of 18.40%. This combination of factors contributes to the stock's rising price, reflecting investor confidence in Aster DM Quality Care Ltd.

Which are the latest news on Aster DM Quality?

Should I buy, sell or hold Aster DM Healthcare Ltd?

Are Aster DM Healthcare Ltd latest results good or bad?

Aster DM Healthcare Ltd's latest Q4 FY26 results show strong profit growth with a net profit of ₹140.17 crores, up 167.24% quarter-on-quarter, but a slight revenue decline of 0.29% raises concerns about future growth. Overall, the results are good in terms of profitability but highlight potential challenges in sustaining revenue momentum.

Aster DM Healthcare Ltd's latest results for Q4 FY26 present a mixed picture. On one hand, the company reported a consolidated net profit of ₹140.17 crores, which is a remarkable increase of 167.24% quarter-on-quarter and 77.39% year-on-year. This strong profit growth was largely driven by an exceptionally low effective tax rate of 5.98%, which significantly boosted the bottom line.<BR><BR>However, the net sales for the same quarter were ₹1,182.38 crores, reflecting a slight decline of 0.29% from the previous quarter, although it did show an 18.20% increase compared to the same quarter last year. This marginal sequential revenue decline raises concerns about the company's near-term growth momentum, especially in a competitive market.<BR><BR>The operating margin improved to 19.67%, up 185 basis points from the previous quarter, indicating better operational efficiency. Additionally, the company's return on equity (ROE) stands at a strong 18.66%, showcasing effective capital utilization.<BR><BR>In summary, while the profit figures are impressive and indicate strong operational improvements, the flat revenue growth and the exceptional tax benefits may not be sustainable in the long term. Therefore, the overall assessment of the results can be seen as good in terms of profitability but raises questions about future revenue growth.

When is the next results date for Aster DM Healthcare Ltd?

The next results date for Aster DM Healthcare Ltd is August 5, 2026.

The next results date for Aster DM Healthcare Ltd is scheduled for August 5, 2026.

What does Aster DM Health. do?

Aster DM Healthcare Ltd is a prominent healthcare provider in the GCC and India, established in 2008 and publicly listed since 2013, with a market cap of INR 41,592 Cr. As of March 2026, it reported net sales of 1,182 Cr and a net profit of 140 Cr.

Overview: <BR>Aster DM Healthcare Ltd is a leading healthcare provider in the GCC and India, operating within the hospital industry and classified as a small-cap company.<BR><BR>History: <BR>Aster DM Healthcare Ltd was established as 'Aster DM Healthcare Private Limited' on 18 January 2008 and was converted into a public limited company on November 29, 2013. The most recent quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 1,182 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 140 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 41,592 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 103.00 <BR>Industry P/E: 60 <BR>Dividend Yield: 0.51% <BR>Debt Equity: 0.20 <BR>Return on Equity: 8.90% <BR>Price to Book: 8.95<BR><BR>Contact Details: <BR>Address: IX/475L Aster Medcity, Kuttisahib Road Cheranalloore Kochi Kerala : 682027 <BR>Tel: 91-0484-6699228 <BR>Email: investors@asterdmhealthcare.com <BR>Website: http://www.asterdmhealthcare.com

How big is Aster DM Health.?

As of 10th June, Aster DM Healthcare Ltd has a market capitalization of 41,592.00 Cr, with recent net sales of 4,643.22 Cr and a net profit of 388.14 Cr. Shareholder's funds are 3,428.07 Cr and total assets amount to 6,600.17 Cr as of March 2025.

As of 10th June, Aster DM Healthcare Ltd has a market capitalization of 41,592.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Aster DM Healthcare reported Net Sales of 4,643.22 Cr and a Net Profit of 388.14 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 3,428.07 Cr and Total Assets of 6,600.17 Cr.

Who are in the management team of Aster DM Health.?

The management team of Aster DM Health includes Chairman Mandayapurath Azad Moopen, Executive Director Alisha Moopen, and several Non-Executive and Independent Directors, along with Company Secretary Hemish Purushottam, who collectively oversee the company's operations and strategy.

The management team of Aster DM Health includes the following individuals:<BR><BR>1. **Mandayapurath Azad Moopen** - Chairman & Executive Director<BR>2. **Alisha Moopen** - Executive Director / Deputy Managing Director<BR>3. **Thadathil Wilson** - Non-Executive Director<BR>4. **Anoop Moopen** - Non-Executive Director<BR>5. **Shamsudheen Bin Mohideen Mammu Haji** - Non-Executive Director<BR>6. **Daniel Robert Mintz** - Non-Executive Director<BR>7. **C J George** - Independent Non-Executive Director<BR>8. **James Mathew** - Independent Non-Executive Director<BR>9. **Wayne Earl Keathley** - Independent Non-Executive Director<BR>10. **Mr. Emmanuel David Gootam** - Independent Non-Executive Director<BR>11. **DEEPTI PURANA HOUSDURGAMVIJAYA** - Independent Non-Executive Director<BR>12. **Hemish Purushottam** - Company Secretary & Compliance Officer<BR><BR>This team plays a crucial role in overseeing the operations and strategic direction of the company.

Who are the peers of the Aster DM Health.?

Aster DM Health's peers include Apollo Hospitals, Max Healthcare, Fortis Health, Narayana Hrudaya, Global Health, Krishna Institute, Dr Agarwal's Health, Rainbow Child, and Health.Global. Aster DM Health has a good management risk rating, below average growth, and an average capital structure, with a 1-year return of 42.45%, outperforming its peers.

Peers: The peers of Aster DM Health are Apollo Hospitals, Max Healthcare, Fortis Health, Narayana Hrudaya, Global Health, Krishna Institute, Dr Agarwal's Health, Rainbow Child, and Health.Global.<BR><BR>Quality Snapshot: Excellent management risk is observed at Apollo Hospitals, Narayana Hrudaya, Global Health, and Rainbow Child, while Average management risk is found at Max Healthcare, Fortis Health, Dr Agarwal's Health, and Health.Global. Good management risk is noted for Aster DM Health and Krishna Institute. For growth, Excellent growth is seen at Apollo Hospitals, Max Healthcare, Fortis Health, and Narayana Hrudaya, while Below Average growth is recorded for Aster DM Health, Global Health, Krishna Institute, and Rainbow Child, with the rest showing Good growth. In terms of Capital Structure, Excellent capital structure is present at Max Healthcare and Global Health, while Average capital structure is noted for Aster DM Health, and Good capital structure is found at Fortis Health, Narayana Hrudaya, Krishna Institute, Dr Agarwal's Health, and Rainbow Child.<BR><BR>Return Snapshot: Aster DM Health has a 1-year return of 42.45%, which is higher than the peer with the highest return, Fortis Health at 27.93%, and significantly higher than the peer with the lowest return, Max Healthcare at -14.68%. Additionally, Global Health and Health.Global have negative six-month returns.

Is Aster DM Health. overvalued or undervalued?

As of December 2, 2025, Aster DM Health is considered overvalued with a PE ratio of 92.00 and high valuation metrics compared to peers, despite a strong year-to-date return of 29.47%.

As of 2 December 2025, the valuation grade for Aster DM Health has moved from very expensive to expensive, indicating a slight improvement in perceived value but still reflecting high valuation metrics. The company is currently considered overvalued. Key ratios include a PE ratio of 92.00, an EV to EBITDA of 42.07, and a Price to Book Value of 7.60, all of which are significantly higher than industry norms.<BR><BR>In comparison to peers, Aster DM Health's PE ratio is notably higher than Apollo Hospitals at 62.27 and Narayana Hrudaya at 45.93, both of which are categorized as expensive. Additionally, Aster's PEG ratio stands at 0.00, suggesting no growth expectations priced into the stock, which is concerning. Despite a strong year-to-date return of 29.47% compared to the Sensex's 8.96%, the high valuation metrics indicate that Aster DM Health may not be a prudent investment at its current price of 665.10.

Is Aster DM Health. technically bullish or bearish?

As of November 19, 2025, Aster DM Health's trend is mildly bullish, supported by daily moving averages and KST indicators, despite some caution from the weekly MACD and recent price declines.

As of 19 November 2025, the technical trend for Aster DM Health has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by the daily moving averages indicating a positive trend. However, the weekly MACD is mildly bearish, which introduces some caution. The Bollinger Bands on both weekly and monthly time frames are mildly bullish, suggesting potential upward movement. The KST is bullish on both weekly and monthly charts, reinforcing the positive outlook. Despite recent price declines, the stock has shown strong returns over longer periods, outperforming the Sensex significantly in the 1Y, 3Y, and 5Y periods. Overall, while there are mixed signals, the prevailing trend remains mildly bullish.

How has been the historical performance of Aster DM Health.?

Aster DM Health's historical performance shows strong growth in net sales and profitability metrics, with net sales rising from 2,994.05 Cr in Mar'23 to 4,138.46 Cr in Mar'25, while profit after tax increased from 170.81 Cr to 355.60 Cr. However, total operating income peaked in Mar'22 and has since declined, alongside a significant drop in total assets and liabilities.

Answer:<BR>The historical performance of Aster DM Health shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Aster DM Health's net sales have increased from 2,994.05 Cr in Mar'23 to 4,138.46 Cr in Mar'25, indicating a strong upward trend. However, total operating income peaked at 10,253.28 Cr in Mar'22 before declining to 4,138.46 Cr in Mar'25. The total expenditure, excluding depreciation, rose from 2,544.97 Cr in Mar'23 to 3,373.93 Cr in Mar'25, reflecting increased operational costs. Operating profit (PBDIT) also showed improvement, rising from 449.08 Cr in Mar'23 to 764.53 Cr in Mar'25, while profit before tax increased from 206.68 Cr in Mar'23 to 489.97 Cr in Mar'25. Profit after tax followed a similar trend, growing from 170.81 Cr in Mar'23 to 355.60 Cr in Mar'25. The earnings per share (EPS) surged dramatically from 8.51 in Mar'23 to 107.66 in Mar'25. On the balance sheet, total liabilities decreased significantly from 17,982.66 Cr in Mar'24 to 6,600.17 Cr in Mar'25, while total assets also declined from 17,982.66 Cr to 6,600.17 Cr in the same period. Cash flow from operating activities improved from 157.00 Cr in Mar'24 to 425.00 Cr in Mar'25, while cash flow from investing activities saw a substantial increase to -6,015.00 Cr in Mar'25. Overall, Aster DM Health has experienced a complex financial journey with notable improvements in profitability metrics despite fluctuations in total income and assets.

Who are the top shareholders of the Aster DM Health.?

The top shareholders of Aster DM Health include promoters holding the majority, with Union Investments Private Limited owning 36.06%. Institutional investors, including mutual funds and foreign institutional investors, hold 23.46% and 23.62%, respectively, while individual shareholders collectively own 4.12%.

The top shareholders of Aster DM Health include a mix of promoters, institutional investors, and individual shareholders. The majority of the shares are held by promoters, with Union Investments Private Limited being the largest individual promoter, holding 36.06%. <BR><BR>In terms of institutional holdings, mutual funds account for 23.46% through 23 different schemes, while foreign institutional investors (FIIs) hold 23.62% of the shares. The highest public shareholder is Rimco (Mauritius) Limited, which owns 8.27%. Individual investors collectively hold 4.12% of the company’s shares. <BR><BR>Overall, the shareholding structure reflects a strong presence of promoter and institutional investors in Aster DM Health.

Has Aster DM Health. declared dividend?

Aster DM Healthcare Ltd has declared a 40% dividend, amounting to ₹4 per share, with an ex-date of February 10, 2025. The company has demonstrated strong financial performance, achieving total returns of 577.43% over the past five years.

Aster DM Healthcare Ltd has declared a 40% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 40%<BR>- Amount per share: 4<BR>- Ex-date: 10 Feb 25<BR><BR>Dividend Yield: 1.03%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the company achieved a price return of 18.2%, a dividend return of 0.82%, resulting in a total return of 19.02%.<BR><BR>Over the past year, Aster DM Healthcare Ltd experienced a price return of 61.98%, a dividend return of 1.67%, leading to a total return of 63.65%.<BR><BR>In the 2-year period, the company saw a price return of 114.93%, a dividend return of 43.18%, culminating in a total return of 158.11%.<BR><BR>For the last 3 years, the price return was 207.85%, with a dividend return of 71.70%, resulting in a total return of 279.55%.<BR><BR>In the 4-year period, Aster DM Healthcare Ltd recorded a price return of 285.97%, a dividend return of 79.64%, achieving a total return of 365.61%.<BR><BR>Over the last 5 years, the company experienced a price return of 475.12%, a dividend return of 102.31%, resulting in a total return of 577.43%.<BR><BR>Overall, Aster DM Healthcare Ltd has not only declared a significant dividend but has also shown impressive total returns across multiple periods, indicating strong financial performance and shareholder value enhancement.